This course has expired. View available courses.
Medication Management
Optimising IV iron therapy: the importance of a patient-centred approach – ACRRM
Iron deficiency (ID) is the commonest nutritional deficiency in Australia and can adversely affect a patient’s quality of life. The principles of managing ID in primary care include making a confirmed diagnosis, identifying and addressing the underlying cause of ID, and correcting the deficiency with iron replacement therapy. The benefits of iron replacement therapy include improvements in fatigue, general health, mental health and quality of life. Because ID is significantly under-diagnosed in Australia, there is a major opportunity in general practice for individual and population health improvements through increased awareness and testing of ID, in addition to targeted iron supplementation.
This 1.5-hour accredited activity aims to empower GPs to improve ID diagnosis rates thereby increasing access to effective treatment with a focus on applying a person-centred approach to selecting intravenous (IV) iron replacement therapy and individualising dosing to ensure adequate iron repletion. It features two cases studies and expert video interviews from the faculty.
This educational activity was developed by MDBriefCase at the request, and with funding from Pfizer.
DURATION
1.5 hrs
PROFESSION
Physician
# OF CREDITS
1.5
ACCREDITATION
ACRRM
EXPIRY DATE
2022-12-31
Iron deficiency (ID) is the commonest nutritional deficiency in Australia and can adversely affect a patient’s quality of life. The principles of managing ID in primary care include making a confirmed diagnosis, identifying and addressing the underlying cause of ID, and correcting the deficiency with iron replacement therapy. The benefits of iron replacement therapy include improvements in fatigue, general health, mental health and quality of life. Because ID is significantly under-diagnosed in Australia, there is a major opportunity in general practice for individual and population health improvements through increased awareness and testing of ID, in addition to targeted iron supplementation.
This 1.5-hour accredited activity aims to empower GPs to improve ID diagnosis rates thereby increasing access to effective treatment with a focus on applying a person-centred approach to selecting intravenous (IV) iron replacement therapy and individualising dosing to ensure adequate iron repletion. It features two cases studies and expert video interviews from the faculty.
This educational activity was developed by MDBriefCase at the request, and with funding from Pfizer.
Faculty
Professor Alhossain Khalafallah (Haematologist)
Dr Sandra Minck (GP)
Learning objectives
On completion of this program, GPs will be better able to:
- Recognise the scale and extent of impact that iron deficiency (ID) and iron deficiency anaemia (IDA) has in the community, particular in certain subgroups
- Identify patients at high risk of ID, including IDA, to improve diagnosis rates and access to effective treatment
- Design an individualised approach to selecting IV iron replacement therapy based on optimising patient outcomes through defined targets
- Determine and assess strategies to optimise tolerability and safety of IV iron replacement therapy
Accreditation
This PDP Activity is accredited by The Australian College of Rural & Remote Medicine for 1 hour of Educational Activity and 0.5 hours of Performance Review.
Activity no. 25012
#
of credits: 1.5
Duration: 1.5 hrs
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1.5 hrs
Duration
Physician
Profession
1.5
# of credits
Learning Objectives
On completion of this program, GPs will be better able to:
- Recognise the scale and extent of impact that iron deficiency (ID) and iron deficiency anaemia (IDA) has in the community, particular in certain subgroups
- Identify patients at high risk of ID, including IDA, to improve diagnosis rates and access to effective treatment
- Design an individualised approach to selecting IV iron replacement therapy based on optimising patient outcomes through defined targets
- Determine and assess strategies to optimise tolerability and safety of IV iron replacement therapy
ACRRM
ACCREDITATION
Medication Management
Learning Category
Medication
Topic
0
Price
2022-12-31
Expiry Date
AUS
Region/Language
Course Description
Iron deficiency (ID) is the commonest nutritional deficiency in Australia and can adversely affect a patient’s quality of life. The principles of managing ID in primary care include making a confirmed diagnosis, identifying and addressing the underlying cause of ID, and correcting the deficiency with iron replacement therapy. The benefits of iron replacement therapy include improvements in fatigue, general health, mental health and quality of life. Because ID is significantly under-diagnosed in Australia, there is a major opportunity in general practice for individual and population health improvements through increased awareness and testing of ID, in addition to targeted iron supplementation.
This 1.5-hour accredited activity aims to empower GPs to improve ID diagnosis rates thereby increasing access to effective treatment with a focus on applying a person-centred approach to selecting intravenous (IV) iron replacement therapy and individualising dosing to ensure adequate iron repletion. It features two cases studies and expert video interviews from the faculty.
This educational activity was developed by MDBriefCase at the request, and with funding from Pfizer.
Faculty
Professor Alhossain Khalafallah (Haematologist)
Dr Sandra Minck (GP)
Accreditation
This PDP Activity is accredited by The Australian College of Rural & Remote Medicine for 1 hour of Educational Activity and 0.5 hours of Performance Review.
Activity no. 25012
1.5 hrs
Duration
0
Price
1.5
# of credits
